New Test for Diagnosis of Tuberculosis Meningitis in Patients With HIV
A new point-of-care lateral flow assay featured the same sensitivity as mycobacterial culture in detecting tuberculosis meningitis in adults with HIV.
Diagnostic Testing
COVID-19 Reporting System, CT Severity Score Are Effective Diagnostic Tools
The COVID-19 Reporting and Data System (CO-RADS) in combination with a CT severity score are easy to use diagnostic tools to guide clinicians in diagnosing COVID-19.
Antiretroviral Lab Monitoring
Laboratory monitoring schedule for patients before and after initiation of antiretroviral therapy.
Determining the Optimal Level of Neutralizing Antibodies Key for COVID-19 Plasma Therapy
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
LT-RAMP Provides Accurate and Rapid COVID-19 Detection: A Real World Study
Researchers compared a novel reverse transcription loop-mediated isothermal amplification method to the gold standard, reverse transcription polymerase chain reaction, and assessed the accuracy in detecting SARS-CoV-2.
COVID-19 Molecular Point-of-Care vs PCR Testing Reduces Time to Results
In hospitalized patients with COVID-19, the routine use of molecular point-of-care testing in emergency department admissions was associated with a large reduction in time to results compared with laboratory PCR testing.
Modified Early Warning Score Predicts Deterioration in COVID-19 Patients
Study authors assessed the specificity and positive predictive value of a customized, institutional, early warning score for predicting decompensation in COVID-19 patients.
Diagnostic Circulating Anodic Antigen Test for Schistosoma haematobium Infections
Study authors investigated UCP-LF circulating anodic antigen (CAA) as a potential diagnostic test for Schistosoma haematobium in pregnant women.
Time to Results Faster With Point-of-Care COVID-19 Testing
Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19.
Performance of 5 Immunoassays for SARS-CoV-2 Compared
A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.
-
Loading...
-
Loading...
